Pay in 4 interest-free payments of $5.24 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
Running intranasal Melanotan II research or any cell-based work with this peptide as the sole pharmacological probe produces data that cannot distinguish which receptor did the work
This research does not provide a peptide treatment but rather identifies a peptide pathway that could be targeted to reduce eczema-associated itch, potentially through BNP receptor antagonists
Ethanol was found to have similar fluidizing effects on membranes, with a significant enhancement of lipid diffusion on short timescales [343]
PMC 8704793
COA May interact with other drugs, affecting the therapeutic effect of the drug or increasing the risk of adverse reactions
US$ 23.40
US$ 28.25
US$ 27.52
US$ 23.72
US$ 23.01
US$ 20.71
